On May 11, 2018 a
Letter,Correspondence
was filed
involving a dispute between
Cresco Labs Llc, An Illinois Limited Liability Company,
Cresco Labs New York, Llc,
A New York Limited Liability Company,
and
Eric Sirota,
Fiorello Pharmaceuticals, Inc.,
A New York Corporation,
John Does 1 - 10,
Susan Yoss,
for Commercial Division
in the District Court of New York County.
Preview
FILED: NEW YORK COUNTY CLERK 02/01/2023 07:50 PM INDEX NO. 652343/2018
NYSCEF DOC. NO. 759 RECEIVED NYSCEF: 02/01/2023
EXHIBIT 14
Letter from Director of DOH Medical
Marijuana Program Denying Fiorello’s
Application to Change Ownership, Dated
August 23, 2018
FILED: NEW YORK COUNTY CLERK 02/01/2023 07:50 PM INDEX NO. 652343/2018
NYSCEF DOC. NO. 759 RECEIVED NYSCEF: 02/01/2023
Index No. 652343/2018
FILED: NEW YORK COUNTY CLERK 02/01/2023 07:50 PM INDEX NO. 652343/2018
NYSCEF DOC. NO. 759 RECEIVED NYSCEF: 02/01/2023
August 23, 2018
VIA CERTIFIED AND ELECTRONIC MAIL to eric@fpnys.com
Eric Sirota
Co-Chief Executive Officer
Fiorello Pharmaceuticals
12 East 49th Street, 11th Floor
New York, New York 10017
Dear Mr. Sirota:
This letter is in response to your email dated July 12, 2018, requesting the review and
approval of the New York State Department of Health (Department) for an ownership change of
Fiorello Pharmaceuticals (Fiorello) to Green Thumb Industries (GTI). The proposed ownership
change would result in GTI, a proposed new investor, owning one hundred percent of Fiorello.
The Department issued a registration to Fiorello on August 1, 2017. Pursuant to 10
NYCRR § 1004.8, the registration issued to Fiorello is non-transferrable. The Department has
reviewed your request and hereby denies the proposed change in ownership, as it would
constitute a direct transfer of the registration.
In addition, Fiorello has not demonstrated progress toward beginning operations.
Pursuant to 10 NYCRR § 1004.9, a registered organization is required to surrender its
registration to the Department upon written notice and demand if the registered organization
fails to begin operations, to the satisfaction of the Department, of a manufacturing and/or
dispensing facility within six months of the date of issuance of the registration. The Department
has provided flexibility with this requirement to help support a phased-in approach of new
registered organizations. Nonetheless, based on documentation submitted by Fiorello to the
Department, it appears that Fiorello is unable to begin operations to the satisfaction of the
Department without the proposed change in ownership with GTI. Please submit an updated
timeline demonstrating how Fiorello will begin operations, to the satisfaction of the Department,
by the end of the calendar year.
Please submit a confirmatory email to mmp@health.ny.gov to acknowledge receipt of
this letter. Should you have any questions concerning this letter, please feel free to contact me
directly at (518) 402-0705.
Sincerely,
Nicole K. Quackenbush, Pharm.D.
Director
Medical Marijuana Program
Document Filed Date
February 01, 2023
Case Filing Date
May 11, 2018
Category
Commercial Division
For full print and download access, please subscribe at https://www.trellis.law/.